BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Chiltern International Ltd. Wins CRO Leadership Award From Life Science Leader


3/11/2013 12:52:45 PM

London, UK, and Wilmington, NC, US, March 11, 2013: Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leader publication based on the data-driven research of Nice Insight.

The CRO Leadership Awards were developed to better serve pharmaceutical and biopharmaceutical executives in their vetting process of CROs when they have a new project. On an annual basis, Nice Insight conducts a pharmaceutical and biotechnology survey deployed to over 40,000 outsourcing-facing biotech and pharma executives. Only CROs scoring in the top 20% in each category qualify as CRO Leaders and are selected from over 200 CROs world-wide. Chiltern is one of three CROs winning in all five categories.

Jim Esinhart, Chiltern CEO, commented, “Chiltern is delighted to be recognized by members of the biopharmaceutical industry as a CRO leader in Quality, Reliability, Productivity, Innovation and Regulatory. Chiltern has been serving clients for more than 30 years and has established a track record around the world as an innovative, efficient and flexible full service CRO. It is a great pleasure to accept this award on behalf of all Chiltern colleagues.”

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,500 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

For More Information Contact:

Natalie Chong, Marketing Director S

Chiltern International Ltd. Ch

171 Bath Road 124

Slough, Berkshire SL1 4AA, UK B

Tel: +44 (0) 1753 512 000 T

Email: natalie.chong@chiltern.com

usan Ojanen, Marketing Executive

iltern International Inc.

1 Volunteer Parkway, Suite 950

ristol, TN 37620, USA

el: +1 (423) 968 9533

Email: susan.ojanen@chiltern.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES